Day: January 26, 2024

Optimind Pharma – Debenture Conversion

TORONTO, ON / ACCESSWIRE / January 26, 2024 / Optimind Pharma Corp. (CSE:OMND) (the “Optimind” or the “Company”) advises that it has reached agreement with holders of principal amount $303,750 convertible debentures maturing on Janu…

Read More

Optimind Pharma – Debenture Conversion

TORONTO, ON / ACCESSWIRE / January 26, 2024 / Optimind Pharma Corp. (CSE:OMND) (the “Optimind” or the “Company”) advises that it has reached agreement with holders of principal amount $303,750 convertible debentures maturing on Janu…

Read More

Nutriband CEO Publishes Letter to Shareholders

ORLANDO, FL / ACCESSWIRE / January 26, 2024 / Nutriband Inc. (“Company”) (NASDAQ:NTRB)(NASDAQ:NTRBW) today announced that CEO Gareth Sheridan has published a letter to shareholders providing insights on achievements and targets through 2023 a…

Read More